Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)
Agency: National Institutes of Health
- 93.351 -- Research Infrastructure Programs
Forecasted opportunityLast Updated: Oct 13, 2026
Important dates
- Forecasted post date: November 25, 2027
- Forecasted application due date: January 25, 2028
- Forecasted award date: July 30, 2028
- Forecasted project start date: August 1, 2028
- Fiscal Year: 2028
Award details
- Expected project funding: Not specified
- Expected awards: 3
Award min.
$580,000
Award max.
$900,000
- Funding opportunity number:PAR-28-084
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Forecast posted date: October 13, 2026
- Archive date: Not specified
- Version: 1
Summary
This Notice of Funding Opportunity (NOFO) invites applicants to support Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications. Each center will provide resources and testing services to the growing community, developing new genome editing technologies and conducting preclinical testing based on these technologies for therapeutics for human diseases. The testing centers will work with NIH-funded investigators to assess the efficacy and safety of genome editing and delivery technologies, determine genome editing thresholds for specific diseases associated with minimal off-target effects, and ascertain feasibility parameters in model systems. This NOFO is especially interested in the application of new approach methodologies (NAMs) to complement traditional in vivo models for the purposes described in this announcement.
The Testing Centers will establish in vivo and in vitro research models applicable to human health and disease, including NAMs and human-biology-based models. The Testing Centers will develop assays and Standard Operating Procedures (SOPs) for evaluating new genome editing technologies. Data generated by the Centers will help determine whether a treatment strategy using a specific set of tools is effective, has an acceptable safety profile, or requires significant improvement in editing efficacy and specificity. Although each Testing Center will work on a limited number of focused projects, the program and pipeline(s) developed are expected to support multifaceted research activities, build core model systems that can be adapted to accommodate a broad spectrum of diseases, and provide fee-for-service resources to the wider biomedical community on a local, regional, and national basis.
The goal of projects supported by this NOFO is to provide research resources that facilitate optimization and enhance scientific rigor, transparency, and experimental reproducibility in biomedical research.
Eligibility
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
Business
- For-profit organizations other than small businesses
- Small businesses
Government
- Federally recognized Native American tribal governments
- State governments
- Special district governments
- Public and Indian housing authorities
- County governments
- City or township governments
Miscellaneous
- Other
Education
- Independent school districts
- Private institutions of higher education
- Public and state institutions of higher education
Additional information on eligibility
Documents
No documents are currently available.
Agency contact information
Email: ORIPDCM@mail.nih.gov
ORIPDCM@mail.nih.gov
Link to additional information
No additional information is available
HHS.gov
An official website of the U.S. Department of Health and Human Services
